Identification of anti-gastric cancer effects and molecular mechanisms of resveratrol: From network pharmacology and bioinformatics to experimental validation

被引:4
|
作者
Ma, Ying-Qian [1 ,2 ]
Zhang, Ming [1 ,5 ]
Sun, Zhen-Hua [1 ]
Tang, Hong-Yue [3 ]
Wang, Ying [2 ]
Liu, Jiang-Xue [2 ]
Zhang, Zhan-Xue [4 ]
Wang, Chao [3 ]
机构
[1] Hebei Gen Hosp, Dept Oncol, Shijiazhuang 050051, Hebei, Peoples R China
[2] Hebei Med Univ, Sch Grad Studies, Shijiazhuang 050017, Hebei, Peoples R China
[3] Hebei Gen Hosp, Clin Med Res Ctr, Shijiazhuang 050051, Hebei, Peoples R China
[4] Hebei Med Univ, Hosp 2, Dept Gastrointestinal Surg, Shijiazhuang 050000, Hebei, Peoples R China
[5] Hebei Gen Hosp, Dept Oncol, 348 Heping West Rd, Shijiazhuang 050051, Hebei, Peoples R China
关键词
Resveratrol; Gastric cancer; Network pharmacology; Bioinformatics; Molecular docking; CELL-CYCLE; C-FOS; PROLIFERATION; INHIBITORS; PROTEIN;
D O I
10.4251/wjgo.v16.i2.493
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND Gastric cancer (GC) is one of the most aggressive malignancies with limited therapeutic options and a poor prognosis. Resveratrol, a non-flavonoid polyphenolic compound found in a variety of Chinese medicinal materials, has shown excellent anti-GC effect. However, its exact mechanisms of action in GC have not been clarified. AIM To identify the effects of resveratrol on GC progression and explore the related molecular mechanisms. METHODS Action targets of resveratrol and GC-related targets were screened from public databases. The overlapping targets between the two were confirmed using a Venn diagram, and a "Resveratrol-Target-GC" network was constructed using Cytoscape software version 3.9.1. The protein-protein interaction (PPI) network was constructed using STRING database and core targets were identified by PPI network analysis. The Database for Annotation, Visualization and Integrated Discovery database was used for Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis. A "Target-Pathway" network was created by using Cytoscape 3.9.1. The RNA and protein expression levels of core target genes were observed using the Cancer Genome Atlas and the Human Protein Atlas databases. DriverDBv3 and Timer2.0 databases were used for survival and immune infiltration analysis. Subsequently, the findings were further verified by molecular docking technology and in vitro experiments. RESULTS A total of 378 resveratrol action targets and 2154 GC disease targets were obtained from public databases, and 181 intersection targets between the two were screened by Venn diagram. The top 20 core targets were identified by PPI network analysis of the overlapping targets. GO function analysis mainly involved protein binding, identical protein binding, cytoplasm, nucleus, negative regulation of apoptotic process and response to xenobiotic stimulus. KEGG enrichment analysis suggested that the involved signaling pathways mainly included PI3K-AKT signaling pathway, MAPK signaling pathway, IL-17 signaling pathway, TNF signaling pathway, ErbB signaling pathway, etc. FBJ murine osteosarcoma viral oncogene homolog (FOS) and matrix metallopeptidase 9 (MMP9) were selected by differential expression analysis, and they were closely associated with immune infiltration. Molecular docking results showed that resveratrol docked well with these two targets. Resveratrol treatment arrested the cell cycle at the S phase, induced apoptosis, and weakened viability, migration and invasion in a dose-dependent manner. Furthermore, resveratrol could exhibit anti-GC effect by regulating FOS and MMP9 expression. CONCLUSION The anti-GC effects of resveratrol are related to the inhibition of cell proliferation, migration, invasion and induction of cell cycle arrest and apoptosis by targeting FOS and MMP9.
引用
收藏
页码:493 / 513
页数:22
相关论文
共 50 条
  • [1] Exploring the anti-gastric cancer mechanism of action of Bidentis Bipinnatae Herba based on network pharmacology, molecular docking, and cellular experimental validation
    Guo, Linglong
    Zhou, Yuyi
    Ma, Rui
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, 397 (11) : 8681 - 8690
  • [2] Investigating the Molecular Mechanisms of Resveratrol in Treating Cardiometabolic Multimorbidity: A Network Pharmacology and Bioinformatics Approach with Molecular Docking Validation
    Gong, Wei
    Sun, Peng
    Li, Xiujing
    Wang, Xi
    Zhang, Xinyu
    Cui, Huimin
    Yang, Jianjun
    NUTRIENTS, 2024, 16 (15)
  • [3] Based on Network Pharmacology, Molecular Docking and Experiments to Explore the Anti-gastric Cancer Effect of Apigenin
    Mahetijiang, Maolidan
    Wang, Junlong
    Nuerxiati, Rehebati
    Li, Ziwei
    Science and Technology of Food Industry, 2024, 45 (21) : 368 - 377
  • [4] Mechanisms of resveratrol against diabetic wound by network pharmacology and experimental validation
    Youjun, Ding
    Huang, Yumeng
    Lai, Yongxian
    Ma, Zhouji
    Wang, Xin
    Chen, Bin
    Ding, Xiaofeng
    Tan, Qian
    ANNALS OF MEDICINE, 2023, 55 (02)
  • [5] Mechanisms of Compound Kushen Injection for the treatment of bladder cancer based on bioinformatics and network pharmacology with experimental validation
    ZHANG LiHui
    ZHANG WanYing
    XIONG JiaMing
    DUAN XiuMei
    HAI LiNa
    ZHANG YuLiang
    ZHANG MiaoMiao
    QIN GuiFang
    ZHANG GuoWei
    Chinese Journal of Natural Medicines, 2022, 20 (01) : 43 - 53
  • [6] Mechanisms of Compound Kushen Injection for the treatment of bladder cancer based on bioinformatics and network pharmacology with experimental validation
    Zhang Li-Hui
    Zhang Wan-Ying
    Xiong Jia-Ming
    Duan Xiu-Mei
    Hai Li-Na
    Zhang Yu-Liang
    Zhang Miao-Miao
    Qin Gui-Fang
    Zhang Guo-Wei
    CHINESE JOURNAL OF NATURAL MEDICINES, 2022, 20 (01) : 43 - 53
  • [7] Integrating network pharmacology, bioinformatics, and experimental validation to unveil the molecular targets and mechanisms of galangin for treating hepatocellular carcinoma
    Li, Xiaoliang
    Zhou, Mingyan
    Chen, Weijia
    Sun, Jiangbo
    Zhao, Yihang
    Wang, Gaoan
    Wang, Bingshu
    Pan, Yipeng
    Zhang, Junqing
    Xu, Jian
    BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2024, 24 (01)
  • [8] Network pharmacology and in vitro experiments to investigate the anti-gastric cancer effects of paeoniflorin through the RAS/MAPK signaling pathway
    Yang, Yating
    Yuan, Ling
    Du, Yuhua
    Ye, Mengyi
    Lu, Doudou
    Huang, Shicong
    Zhao, Jianjun
    Tibenda, Joanna Japhet
    Meng, Fandi
    Nan, Yi
    DISCOVER ONCOLOGY, 2024, 15 (01)
  • [9] Celastrol as a candidate drug for silicosis: From bioinformatics and network pharmacology to experimental validation
    Liang, Chao
    Bai, Ying
    Miao, Rui
    Yang, Xuelian
    Liu, Yafeng
    Zhou, Jiawei
    Guo, Jianqiang
    Hu, Dong
    Wu, Jing
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 125
  • [10] Bioinformatics and network pharmacology identify promotional effects and potential mechanisms of ethanol on esophageal squamous cell carcinoma and experimental validation
    Huang, Ming
    Wu, Zhongbing
    Jia, Lei
    Wang, Yu
    Gao, Shuang
    Liu, Ying
    Zhang, Yushuang
    Li, Jing
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2023, 474